Eevia Health Plc receives multiple sales orders for c. KSEK 518 (KEUR 50) Eevia Health ("Eevia" or "The Company") received several sales orders totaling c 518 kSEK (50 kEUR) from various European customers.
Eevia Health Plc finalizes a key development project and receives grant payment for c. 2,747 KSEK (243 KEUR) Eevia Health ("Eevia" or "The Company") has finalized a development project for the documentation of bioactivity on its products, which was co-funded by Business Finland. Eevia e...
Eevia Health Plc receives a KSEK 1,472 (KUSD 142) sales order for Feno-Sambucus™ 7 Organic Eevia Health ("Eevia" or "The Company") received a 1,472 kSEK / 142 kUSD blanket sales order for the elderberry extract Feno-Sambucus™ 7 Organic from a distributor in the US.
REG
Eevia Health Plc revises its Information Policy Eevia Health Plc ("Eevia" or "The Company") has revised its Information Policy and changed the threshold for orders to 566 KSEK (50 KEUR).
REG MAR
Eevia Health Plc Year End Report - 2023 Eevia Health Plc ("Eevia" or "The Company") is releasing its year-end financial report for the full year of 2023, as well as for Quarter 4, 2023.
REG MAR
Eevia Health Plc engages with a global market leader to evaluate collaboration on the launch of a novel dietary eye-health ingredient Eevia Health Plc ("Eevia" or "The Company") is exchanging confidential information with a global market leader in eye health regarding a novel ingredient Eevia developed over the...
REG MAR
Eevia Health Plc has secured a credit line of SEK 7.2 million for working capital purposes to finance continued growth Eevia Health Plc, ("Eevia" or "The Company"), has entered into an agreement whereby Råsunda Förvaltning AB, Upgrade Invest Nordic AB, and Renewable Ventures Nordic AB will provid...
Eevia Health Plc received a 445 KSEK / 39 KEUR sales order for a Bilberry extract Eevia Health Plc's ("Eevia" or "The Company") has received a 39 KEUR sales order from a French distributor Natural Ingredients, for Feno-Myrtillus 25, a bilberry extract. The sal...
Eevia Health Plc received a 159 KSEK / 14 KEUR sales order for a pine bark extract product Eevia Health Plc's ("Eevia" or "The Company") has received a 14 KEUR sales order from a US company for Fenoprolic®  70 Organic, an organically certified pine bark extract.
Eevia Health Plc received a 112 KSEK / 10 KEUR sales order for a Bilberry extract product Eevia Health Plc's ("Eevia" or "The Company") has received a 10 KEUR sales order from a US company for Feno-Myrtillus 25 organic, an organically certified bilberry extract.
Eevia Health Plc receives a 289 KSEK / 25 KEUR sales order for a Lingonberry extract product Eevia Health Plc ("Eevia" or "The Company") has received a 25 KEUR sales order for a Lingonberry extract from a Finnish beauty brand.
REG MAR
Eevia Health Plc enters negotiations for a significant sales contract for 2025 with an option to extend until 2027 Eevia Health Plc ("Eevia" or the "Company") has entered negotiations with a European food manufacturer to manufacture a new plant extract (the "Product") with the potential for s...
Eevia Health Plc received two sales orders totaling 516 kSEK / 46 kEUR for Bilberry juice powder made from side streams of Eevia's main berry extract production Eevia Health Plc's ("Eevia" or "The Company") has received a 46 kEUR (516 kSEK) sales order from a Finnish customer for organically certified Bilberry Juice powder. Eevia receive...
Eevia Health Plc reorganizes distribution in North America Eevia Health Plc's ("Eevia" or "The Company") has reorganized distribution in North America with an objective to have a more transparent the value chain beyond the distributors,...
Eevia Health Plc received an increase of 115 kSEK / 11 kEUR to an earlier sales order for a Bilberry extract worth 228 SEK / 21 kEUR Eevia Health Plc's ("Eevia" or "The Company") has received an extension of 11 kEUR (115 kSEK) to the sales order of 22 kEUR (228 kSEK) which was press released by Eevia on Decemb...
Eevia Health Plc received a multiple sales order for extract products with combined value of 347 KSEK / 31 KEUR Eevia Health Plc's ("Eevia" or "The Company") has received a series of smaller orders worth a total of 31 KEUR sales order from Slovenian and Taiwanese customers for organically...
Eevia Health Plc receiveS A 763 Ksek (69 KEUR) sales order for Feno-Sambucus™ 7 Organic Eevia Health ("Eevia" or "The Company") received a 763 kSEK / 69 kEUR sales order for the elderberry extract Feno-Sambucus™ 7 ORGANIC from a distributor in the US.
Eevia Health Plc received a 434 KSEK / 39 KEUR sales order for a Bilberry extract product Eevia Health Plc's ("Eevia" or "The Company") has received a 39 KEUR sales order from French distributor Natural Ingredients, for Feno-Myrtillus 25 organic, an organically certif...

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.

Webbplats
eeviahealth.com/investors

Handelsinformation

Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658

IR-Kontakt

Stein Ulve IR-kontakt [email protected]